| Literature DB >> 35564016 |
Sinan Chen1, Yifei Xu1, Ni Cheng1,2, Feng Li3, Haoan Zhao1, Naisheng Bai1, Hesham R El-Seedi4,5, Wei Cao1,2.
Abstract
Colitis is an inflammatory disease that results from the overactivation of effector immune cells, producing a high quantity of pro-inflammatory cytokines. Our study aimed to explore whether buckwheat (F. esculentum) bee pollen extract (FBPE) could inhibit the progression of dextran sulfate sodium (DSS)-induced colitis via regulating immune function. We isolated and identified six main phenolic compounds of FBPE such as luteolin (9.46 mg/g) by column chromatography, HPLC-DAD, ESI-MS and NMR spectroscopy, then assessed their effects on colonic mucosal injury by clinical symptoms, histomorphology and immunohistochemistry examinations. The results showed that FBPE at 25.2 g/kg body weight (g/kg BW) changed the clinical symptoms of colitis, the ICAM-1 expression in colon, the activity of related inflammatory mediators in colon tissue and helped restore the immune system. Compared with the model group (40.28%), the CD4 positivity was significantly reduced in the HD (High-dose group: 25.2 g FBPE/kg BW/day) group (20.45%). Administration of 25.2 g/kg BW of FBPE decreased the IFN-γ, TNF-α and IL-4 levels, while enhancing the IL-10 level, and significantly inhibited the abnormally decreased IgG (Model: 13.25 mg/mL, HD: 14.06 mg/mL), showing a reversal effect on the Th1/Th2 levels in colitis. These findings suggested that FBPE at 25.2 g/kg BW had the effects of alleviating colitis and immunomodulation, which can help in the development of safe and effective immune therapy.Entities:
Keywords: Th1/Th2; buckwheat bee pollen; colitis; immunity; phenolic compounds
Year: 2022 PMID: 35564016 PMCID: PMC9105923 DOI: 10.3390/foods11091293
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1The experimental grouping and design.
Primer sequences for qPCR.
| Primer | F | R |
|---|---|---|
| TNF-α | 5′-AGCCGATGGGTTGTACCTTG-3′ | 5′-AGTACTTGGGCAGATTGACCTC-3′ |
| IFN-γ | 5′-AGGTCCAGCGCCAAGCATTCAA-3′ | 5′-AGCAGCGACTCCTTTTCCGCTT-3′ |
| IL-4 | 5′-AACGTCCTCACAGCAACGAA-3′ | 5′-AGGCATCGAAAAGCCCGAAA-3′ |
| IL-10 | 5′-CAGTACAGCCGGGAAGACAA-3′ | 5′-CCTGGGGCATCACTTCTACC-3′ |
| β-actin | 5′-CACGATGGAGGGGCCGGACTCATC-3′ | 5′-TAAAGACCTCTATGCCAACACAGT-3′ |
Figure 2Effects of FBPE on colitis symptoms and colonic lesions, including body weight (A), food intake (B), disease activity index (DAI) (C), colon weights (D), typical images for length comparison of colon samples (E), spleen weights (F), typical images for swelling level comparison of spleen samples (G), H&E staining of colon sections and its semi-quantitative histological scoring (H), ICAM-1 immunohistochemical colon sections and score (I). Arrows represent the expression of ICAM-1. Different lower-case letters correspond to a significant difference of p < 0.05.
Figure 3Effect of FBPE on the inflammatory mediators in the mice colon with DSS-induced colitis. SOD activity (A), GSH-Px activity (B), MPO activity (C) and NO content (D). Different lower-case letters correspond to a significant difference at p < 0.05.
Figure 4Effect of FBPE on immune response in splenocytes, colon and serum of DSS-induced colitis. GSH, GSSG content and GSH/GSSG ratio in splenocytes (A), T cell subsets content in splenocytes (B), inflammatory cytokines mRNA levels in colon (C), immunoglobulin (IgG, IgA and IgM) content in serum (D). Different lower-case letters correspond to a significant difference at p < 0.05.